medigraphic.com
ENGLISH

Annals of Hepatology

Órgano Oficial de la Asociación Mexicana de Hepatología
  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2006, Número S1

<< Anterior Siguiente >>

Ann Hepatol 2006; 5 (S1)


Module ll
Diagnosis of patients with suspected chronic hepatitis C virus infection

Hevia UFJ
Texto completo Cómo citar este artículo

Idioma: Ingles.
Referencias bibliográficas: 12
Paginas: 15-18
Archivo PDF: 47.82 Kb.


PALABRAS CLAVE

Sin palabras Clave

FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Screening for hepatitis C virus infection in adults: recommendation statement. Ann Intern Med 2004; 140: 462.

  2. Calonge N, Randhawa G. The meaning of the U.S. Preventive Services Task Force grade I recommendation: screening for hepatitis C virus infection. Ann Intern Med 2004; 141: 718.

  3. Alter MJ, Seeff LB, Bacon BR, et al. Testing for hepatitis C virus infection should be routine for persons at increased risk for infection. Ann Intern Med 2004; 141: 715.

  4. Sheth SG, Flamm SL, Gordon FD, Chopra S. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1998; 93: 44.

  5. Marcellin P, Levy S, Benhamou JP, Erlinger S. Management of the asymptomatic HCV carrier with normal ALT levels. Viral Hepatitis Rev 1996; 2: 227.

  6. Scheuer PJ, Asharafzadeh P, Sherlock S, et al. The pathology of hepatitis C. Hepatology 1992; 15: 567.

  7. Gretch DR. Diagnostic tests for hepatitis C. Hepatology 1997; 26: 43S.

  8. Busch MP, Tobler LH, Tegtmeier G, et al. Use of third-generation hepatitis C virus (HCV) enzyme immunoassay (EIA) to resolve second-generation HCV EIA- reactive and second-generation recombinant immunoblot assay-indeterminate blood samples: data to support current Food and Drug Administration guidance on HCV lookback. Transfusion 2000; 40: 10.

  9. Uyttendaele S, Claeys H, Mertens W, et al. Evaluation of thirdgeneration screening and confirmatory assays for HCV antibodies. Vox Sang 1994; 66: 122.

  10. Pawlotsky JM, Lonjon I, Hezode C, et al. What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? Hepatology 1998; 27: 1700.

  11. Gretch DR, dela Rosa C. Carithers RL Jr, et al. Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications. Ann Intern Med 1995; 123: 321.

  12. Martinot-Peignoux M, Boyer N, Le Breton V, et al. A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C. Hepatology 2000; 31: 726.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ann Hepatol. 2006;5

ARTíCULOS SIMILARES

CARGANDO ...